OIM
MDGL icon

Oracle Investment Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Oracle Investment Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-63,000
Closed -$426K – 40
2021
Q3 		$426K Buy
+63,000
New +$5.44M 0.05% 33

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Oracle Investment Management's MDGL Position: Q4 2021 in Review

Oracle Investment Management sold out of Madrigal Pharmaceuticals (MDGL) in Q4 2021, closing a stake of 38,500 shares — an estimated $3.07M sold.

Oracle Investment Management first reported a position in MDGL in Q3 2021 and held it in 1 quarter. The position peaked at $3.07M in Q3 2021. 144 funds tracked by Wall St. Rank hold MDGL as of Q4 2021.

  • Oracle Investment Management reported no remaining Madrigal Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Oracle Investment Management sold 38,500 Madrigal Pharmaceuticals shares in Q4 2021, an estimated $3.07M.
  • Oracle Investment Management first reported a position in Madrigal Pharmaceuticals in Q3 2021 and held it in 1 quarter.
  • Oracle Investment Management's Madrigal Pharmaceuticals position peaked at $3.07M in Q3 2021.
  • 144 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q4 2021.

Based on Oracle Investment Management's 13F filing for Q4 2021, filed 14 Feb 2022.